Chen et al. found that the GSTM1-null genotype in combination with the CYP1A1 and CYP2D6 heterozygous mutant genotypes was associated with an elevated risk of acute non-lymphoblastic leukemia [11]. The gene discussed is CYP1A1; the disease is acute myeloid leukemia.